Digital Health Views & Analysis | pharmaphorum

Wednesday 10 June 2026

Views & Analysis

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Digital

pharmaphorum podcast Episode 233, Patrick Leung, Faro Health

AI for the planet, AI for life sciences – with Patrick Leung

Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.

Digital

Cracking the code: How European biotechs can win in the US market

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

Digital

Stethoscope and UK flag with NHS on wooden blocks spelled out on top

Six ways the NHS can become the UK’s greatest testbed for te...

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Digital

pharmaphorum podcast Episode 232, Kate Eversole, Celine Parmentier, Emma Slade

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

Digital

pharmaphorum podcast Episode 231, Dr Alan Roth, Oxford Drug Design

On AI and computational support of biochemistry, with Alan R...

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.